Phase I clinical evaluation of CNSA-001 (sepiapterin), a...

  • Main
  • 2019 / 2
  • Phase I clinical evaluation of CNSA-001 (sepiapterin), a...
Molecular Genetics and Metabolism 2019 / 2

Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteers

Smith, Neil, Longo, Nicola, Levert, Keith, Hyland, Keith, Blaud, Nenad
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2019.02.001
Date:
February, 2019
File:
PDF, 3.12 MB
english, 2019
Conversion to is in progress
Conversion to is failed